Peter Ringleb Selected Research

Peter Ringleb Research Topics

35	Stroke (Strokes) 03/2024 - 09/2001
21	Ischemic Stroke 03/2024 - 09/2001
6	Carotid Stenosis (Carotid Artery Stenosis) 06/2021 - 10/2008
6	Hemorrhage 08/2013 - 09/2001
4	Pathologic Constriction (Stenosis) 06/2021 - 07/2006
4	Transient Ischemic Attack 04/2016 - 09/2001
3	Cerebral Hemorrhage 01/2019 - 06/2011
3	Myocardial Infarction 04/2016 - 09/2001
2	Ischemia 01/2023 - 01/2018
2	Infarction (Infarctions) 01/2023 - 12/2013
2	Brain Edema (Cerebral Edema) 01/2023 - 01/2023
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 01/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 01/2009
2	Thrombotic Thrombocytopenic Purpura 10/2002 - 09/2001
2	Coronary Disease (Coronary Heart Disease) 10/2002 - 09/2001
2	Peripheral Arterial Disease 10/2002 - 09/2001
2	Neutropenia 10/2002 - 09/2001
1	Blood Vessel Dissection 05/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypercholesterolemia 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Cerebral Infarction 01/2018
1	Thrombosis (Thrombus) 01/2017
1	Bone Fractures (Bone Fracture) 04/2016
1	Insulin Resistance 04/2016
1	Edema (Dropsy) 04/2016
1	Weight Gain 04/2016
1	Infections 12/2013
1	Embolic Stroke 12/2013
1	Hyperglycemia 08/2013
1	Vascular System Injuries 08/2013
1	Diabetes Mellitus 08/2013
1	Body Weight (Weight, Body) 06/2011
1	Carotid Body Tumor 03/2009
1	Atrial Fibrillation 01/2009
1	Brain Ischemia (Cerebral Ischemia) 07/2005

12	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 01/2005
6	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2023 - 02/2010
3	AnticoagulantsIBA 01/2023 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 08/2013
2	Retinaldehyde (Retinal)IBA 06/2021 - 06/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2012
2	Dipyridamole (Persantine)FDA LinkGeneric 10/2002 - 09/2001
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2002 - 09/2001
2	Clopidogrel (Plavix)FDA Link 10/2002 - 09/2001
2	Warfarin (Coumadin)FDA LinkGeneric 10/2002 - 09/2001
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2002 - 09/2001
2	Ticlopidine (Ticlid)FDA LinkGeneric 10/2002 - 09/2001
1	CholesterolIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	Pioglitazone (Actos)FDA Link 04/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 10/2013
1	2,6-dinitrotoluene (DNT)IBA 10/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2013
1	Tirofiban (Aggrastat)FDA Link 05/2013
1	Glycoproteins (Glycoprotein)IBA 05/2013
1	LipidsIBA 01/2012
1	Nitracrine (C 283)IBA 01/2009
1	Phenprocoumon (Liquamar)FDA Link 01/2009

19	Therapeutics 06/2023 - 01/2005
6	Carotid Endarterectomy 06/2021 - 05/2006
4	Endarterectomy (Thromboendarterectomy) 06/2021 - 10/2008
4	Secondary Prevention 01/2017 - 09/2001
3	Thrombectomy 01/2023 - 05/2013
3	Stents 07/2012 - 07/2006
2	Thrombolytic Therapy 05/2014 - 01/2005
1	Duration of Therapy 11/2019
1	Time-to-Treatment 05/2014
1	Length of Stay 12/2013
1	Treatment Delay 10/2013
1	Contraindications 01/2012
1	Aftercare (After-Treatment) 05/2011